Home › Funds › PSP Research LLC › PTCT
PSP Research LLC position in PTCT
PTC THERAPEUTICS INC · Health Care
PSP Research LLC reported holding 6,000 shares of PTCT (PTC THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$489K, representing 0.26% of its reported portfolio and ranking #21 among its reported holdings. PSP Research LLC has disclosed PTCT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
How PSP Research LLC's PTCT position evolved
PSP Research LLC first disclosed a stake in PTCT in Q4 2025 at 7,046 shares (US$535K). Across 3 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 6,000 shares valued at US$489K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 7.05K | $535.21K | New |
| Q1 2026 | 6.00K | $408.78K | Reduce |
| Q2 2026 | 6.00K | $489.42K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PTCT and 13F data
PTCT (PTC THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in PTCT — the largest reported positions include RTW INVESTMENTS, LP (US$631.9M), TORONTO DOMINION BANK (US$176.7M), WESTFIELD CAPITAL MANAGEMENT CO LP (US$159.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PTCT
- RTW INVESTMENTS, LP 7.75M sh · $631.88M · Q2 2026
- TORONTO DOMINION BANK 2.17M sh · $176.67M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.96M sh · $159.56M · Q2 2026
- Hood River Capital Management LLC 1.74M sh · $141.82M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $122.36M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.44M sh · $117.47M · Q2 2026
- Jefferies Financial Group Inc. 1.36M sh · $110.69M · Q2 2026
- Blue Sparrow, LLC /DE 1.05M sh · $85.71M · Q2 2026
- Palo Alto Investors LP 918.85K sh · $74.95M · Q2 2026
- ARMISTICE CAPITAL, LLC 660.00K sh · $53.84M · Q2 2026
- Parkman Healthcare Partners LLC 435.69K sh · $35.54M · Q2 2026
- Defilade Capital Management, L.P. 433.70K sh · $35.38M · Q2 2026